Everything by Chris.

Health and Healthcare

Why Key Analyst Still Sees Some Upside in Bluebird Bio

Dec 7, 2015 Health and Healthcare

Why Threshold Pharma Is Imploding

Dec 7, 2015 Health and Healthcare

Idera Pharma Soars Over Positive Trial Data

Dec 7, 2015 Health and Healthcare

MEI Pharma Bounces Off Lows After Positive Phase 2 Results

Dec 7, 2015 Retail

Mattress Firm Earnings Not Enough for Investors

Dec 7, 2015 Casinos & Hotels

Vail Resorts Wows Investors Despite Loss

Dec 7, 2015 Services

Does Chipotle Have Even More Downside Than Previously Thought?

Dec 7, 2015 Companies and Brands

Are Keurig Shareholders Getting Enough?

Dec 7, 2015 Investing

Top 7 Earnings Previews for the Week Ahead

Dec 6, 2015 Health and Healthcare

Top 6 BioPharma Movers of the Week

Dec 5, 2015 Banking, finance, and taxes

Is Aflac Still a Buy?

Dec 4, 2015 Infrastructure

NRG Continues to Fall as CEO Steps Down

Dec 4, 2015 Energy

Why Oppenheimer Wants to Chase Warren Buffett in Phillips 66

Dec 4, 2015 Health and Healthcare

KaloBios Continues to Rally on Private Placement

Dec 4, 2015 Retail

Big Lots Rises After Meeting Earnings

Dec 4, 2015 Transportation

Why Merrill Lynch Downgraded Railroads

Dec 4, 2015 Retail

Zumiez Falls Sharply on Missed Guidance

Dec 4, 2015 Technology

Why Ambarella Earnings Aren’t Enough to Overcome Its Outlook

Dec 3, 2015 Retail

Ulta Crushes Earnings With Strong Comps

Dec 3, 2015 Technology

How Analysts View Verint After Earnings

Dec 3, 2015